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Abstract
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We report on the fabrication of covalently crosslinked and amine-reactive hollow microcapsules
using ‘reactive’ layer-by-layer assembly to deposit thin polymer films on sacrificial microparticle
templates. Our approach is based on the alternating deposition of layers of a synthetic polyamine
and a polymer containing reactive azlactone functionality. Multilayered films composed of
branched poly(ethylene imine) (BPEI) and poly(2-vinyl-4,4-dimethylazlactone) (PVDMA) were
fabricated layer-by-layer on the surfaces of calcium carbonate and glass microparticle templates.
After fabrication, these films contained residual azlactone functionality that was accessible for
reaction with amine-containing molecules. Dissolution of the calcium carbonate or glass cores
using aqueous ethylenediamine tetraacetic acid (EDTA) or hydrofluoric acid (HF), respectively,
led to the formation of hollow polymer microcapsules. These microcapsules were robust enough
to encapsulate and retain a model macromolecule (FITC-dextran) and were stable for at least 22
hours in high ionic strength environments, in low and high pH solutions, and in several common
organic solvents. Significant differences in the behaviors of capsules fabricated on CaCO3 and
glass cores were observed and characterized using scanning electron microscopy (SEM) and
energy dispersive X-ray spectroscopy (EDS). Whereas capsules fabricated on CaCO3 templates
collapsed upon drying, capsules fabricated on glass templates remained rigid and spherical.
Characterization using EDS suggested that this latter behavior results, at least in part, from the
presence of insoluble metal fluoride salts that are trapped or precipitate within the walls of
capsules after etching of the glass cores using HF. Our results demonstrate that the assembly of
BPEI/PVDMA films on sacrificial templates can be used to fabricate reactive microcapsules of
potential use in a wide range of fields, including catalysis, drug and gene delivery, imaging, and
biomedical research.

Introduction
Layer-by-layer assembly is a versatile approach to the fabrication of nanostructured thin
films and is typically accomplished by alternating the adsorption of ‘mutually interacting’
polymers on surfaces.1 This approach has been used to design films with applications in
catalysis, nanofiltration, the preparation of superhydrophobic or antimicrobial surface
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coatings, drug and gene delivery, coatings for biomedical devices, and a wide range of other
fields.2 The versatile nature of layer-by-layer assembly permits the fabrication of films that
conformally coat planar macroscopic surfaces as well as surfaces with complex geometries
and microscale features, including micro- and nanoparticles. Multilayered films fabricated
on micrometer-scale colloidal substrates have been used to design particles for gene and
drug delivery, to protect proteins from enzymatic degradation, or to prepare microreactors
and design hollow microcapsules.3 As a general approach for the encapsulation of both large
and small molecules and other agents, layer-by-layer assembly is attractive because the
stability, thickness and permeability of the resulting capsule walls can be controlled and
tuned by selecting appropriate polymers and conditions for the fabrication of the polymer
films.3a
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In this paper, we report an approach to the fabrication of covalently crosslinked and aminereactive microcapsules that involves the layer-by-layer assembly of ‘mutually reactive’
polymers. Many methods for layer-by-layer assembly involve the alternating adsorption of
oppositely charged polyelectrolytes to surfaces to fabricate ‘polyelectrolyte multilayers’ (or
PEMs) held together by electrostatic interactions between adjacent polyelectrolyte layers.1–
2, 2d, 3a However, layer-by-layer fabrication has also been accomplished by exploiting other
interactions, such as hydrogen bonding4 or covalent bonding,5 between polymers containing
complementary functional groups. Of particular relevance to the work described here,
several groups have recently demonstrated the use of ‘click’-type reactions between azideand alkyne-functionalized polymers to fabricate films on sacrificial microparticle cores.6
The subsequent removal of the core leads to hollow polymer microcapsules that are stable in
a wider range of environmental conditions than microcapsules fabricated by electrostatic or
hydrogen bonding layer-by-layer assembly.4a, 4b, 6a, 7 In addition, the presence of residual
reactive functional groups in the film after fabrication allows the capsules to be
functionalized with a wide range of compounds to create capsules with desired properties
(e.g., prevention of non-specific protein adsorption by functionalizing the surfaces of
capsules with polyethylene glycol).6c, 8
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We recently reported a method for the ‘reactive’ assembly of covalently crosslinked
multilayered films using the azlactone-functionalized polymer poly(2-vinyl-4,4dimethylazlactone) (PVDMA).9 The highly strained azlactone rings in PVDMA (see Figure
1A) undergo rapid ring-opening reactions with a variety of nucleophiles, including primary
amines, alcohols and thiols.10 Our past studies demonstrated that ultrathin multilayered
films can be fabricated by the layer-by-layer assembly of PVDMA with branched
poly(ethylene imine) (BPEI), and that the primary amines of BPEI react readily with the
azlactone rings of PVDMA in the absence of a catalyst. This process leads to the formation
of diamide crosslinks (e.g., Figure 1A) between layers of the film without producing any
byproducts.9a We have demonstrated that films fabricated using this approach contain
residual azlactone functionality that is accessible for post-fabrication functionalization with
primary amine-containing molecules, and that this approach can be used to prepare films
with specific surface properties. For example, BPEI/PVDMA films treated with Dglucamine have been demonstrated to resist cell and protein adhesion for up to one month in
vitro.9b We have demonstrated the fabrication of BPEI/PVDMA films on a variety of planar
substrates,9a, 9b at interfaces between immiscible organic and aqueous phases,9d and on
substrates with micron-scale topographical features.9a, 9c
This current study sought to investigate whether this approach could be used to fabricate
reactive hollow microcapsules by fabricating BPEI/PVDMA films on sacrificial
microparticle templates. This approach has several unique features that make it a potentially
attractive alternative to other layer-by-layer approaches for creating reactive microcapsules.
For example, compared to approaches based on the alkyne-azide Huisgen cycloaddition

J Mater Chem. Author manuscript; available in PMC 2012 February 14.

Saurer et al.

Page 3

NIH-PA Author Manuscript

reaction,11 this approach does not require a catalyst to achieve rapid reactions at room
temperature.10 In addition, PVDMA is readily synthesized using conventional and living
polymerization techniques,10, 12 and no additional preparation steps are required after
polymerization to render PVDMA reactive. Finally, the fabrication of BPEI/PVDMA films
is conducted entirely in organic solvents, and could therefore potentially be used to coat the
surfaces of water soluble templates that are not traditionally suitable as substrates for the
aqueous-based layer-by-layer assembly of polyelectrolyte-based films.
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The work reported here is described in two parts. In the first part, we describe the fabrication
of multilayered BPEI/PVDMA films on calcium carbonate microparticles, and we
demonstrate the ability to functionalize the resulting films with amine-functionalized
molecules. Dissolution of CaCO3 cores using aqueous EDTA resulted in the formation of
flexible, hollow microcapsules that were stable in a wide range of aqueous and organic
solutions. In the second part, we describe the fabrication of rigid, hollow microcapsules
using glass microparticle templates that were etched away by treatment using hydrofluoric
acid. Scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS)
were used to characterize significant differences in the behaviors and physical properties of
BPEI/PVDMA microcapsules fabricated using CaCO3 and glass templates. Our results
suggest a general and straightforward approach to the fabrication of reactive and hollow
polymer microcapsules with potential applications in catalysis, drug delivery, imaging, and
other areas of fundamental research.

Materials and Methods
Materials
Branched poly(ethylene imine) (MW = 25,000) and reagent grade acetone were obtained
from Aldrich Chemical Company (Milwaukee, WI). 2-Vinyl-4,4-dimethylazlactone was a
kind gift from Dr. Steven M. Heilmann (3M Corporation, Minneapolis, MN). Calcium
chloride and sodium carbonate were purchased from Fisher Scientific (Pittsburgh, PA).
Soda-lime glass beads (10–30 μm) were obtained from Polysciences Inc. (Warrington, PA).
Ethylenediaminetetraacetic acid (EDTA) was purchased from Acros Organics (Geel,
Belgium). Hydrofluoric acid (HF), reagent grade dimethyl sulfoxide (DMSO), and FITCdextran (MW = 2,000,000) were obtained from Sigma-Aldrich (St. Louis, MO).
Tetramethylrhodamine cadaverine (TMR-cadaverine) was purchased from Invitrogen
Corporation (Carlsbad, CA). Poly(2-vinyl-4,4-dimethylazlactone) (PVDMA, MW = 18,000
– 25,000) was synthesized as previously described.9c, 12a, 13 All materials were used as
received without any additional purification unless noted otherwise.
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Fabrication of Calcium Carbonate Particles
Calcium carbonate microparticles were fabricated using the approach described by DeGeest
et al.14 Briefly, aqueous solutions of calcium chloride and sodium carbonate were prepared
at 0.33 M. Equal volumes of these solutions were mixed rapidly under vigorous stirring for 1
minute. Mixing led to rapid precipitation of CaCO3 microparticles with diameters ranging
from 3–6 μm. The CaCO3 suspension was then centrifuged at full speed in a Centrific
centrifuge (Fisher Scientific) for 5 minutes. The supernatant was decanted and the particles
were rinsed in water to remove residual ions. The particles were centrifuged and rinsed in
water four times. After decanting the supernatant from the fourth rinse in water, the particles
were rinsed twice in acetone and centrifuged to remove water. The supernatant from the
second rinse in acetone was decanted and the particles were dried under a stream of filtered
air. Fabrication of CaCO3 microparticles encapsulating FITC-dextran was accomplished by
dissolving 5 mg FITC-dextran in 3.5 mL of 0.33 M calcium chloride prior to mixing the
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calcium chloride with sodium carbonate, but was otherwise identical to the procedure
described above.
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Fabrication of Multilayered Films on Calcium Carbonate Particles and Glass Beads
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Solutions of BPEI and PVDMA were prepared in acetone (40 mM with respect to the
molecular weight of the polymer repeat unit). Approximately 3 mg of calcium carbonate
particles were weighed out into microcentrifuge tubes and suspended in 250 μL of acetone.
The first layer of BPEI was deposited onto the calcium carbonate particles by adding 250 μL
of the BPEI solution (40 mM) to the particle suspension and vortexing the particles for 5
minutes to allow sufficient time for the polymer to adsorb to the particle surface. The
particles were then centrifuged for 5 minutes at 1000 g. The supernatant was removed by
pipette and the particles were rinsed three times by resuspending them in 500 μL of acetone
and vortexing. After each rinse in acetone, the particles were centrifuged for 5 minutes at
1000 g and the supernatant was removed. After the third acetone rinse, the particles were
resuspended in 250 μL of acetone and transferred by pipette to a new microcentrifuge tube.
The second layer of the multilayered film was fabricated by adding 250 μL of the PVDMA
solution (40 mM) to the particle suspension and vortexing for 1 minute to allow sufficient
time for the PVDMA to react to the previously deposited BPEI layer. The particles were
then rinsed three times with 500 μL of acetone and transferred to a new microcentrifuge tube
in 250 μL of acetone as described above. Subsequent layers were fabricated by repeating
this process, alternately adding BPEI or PVDMA layers and allowing each layer to react for
1 minute, until the desired number of polymer BPEI/PVDMA layer pairs (or ‘bilayers’;
typically 5) were deposited onto the particle surface. After multilayered film fabrication, the
particles were stored in acetone overnight until further use. The coating of glass beads was
performed following the procedure above with the following exceptions: 1) glass beads were
suspended in 700 μL of acetone, 2) 700 μL of polymer solution was added during each of
the deposition steps, 3) glass beads were rinsed in 1 mL of acetone, and 4) glass beads were
not transferred to new microcentrifuge tubes between layers to avoid the loss of glass beads.
The morphology of the coated CaCO3 or glass microparticles was characterized using
scanning electron microscopy (SEM) as described below.
Post-Fabrication Functionalization of Coated Particles
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To characterize the presence and accessibility of residual azlactone groups contained in the
BPEI/PVDMA films, the films were functionalized using a variety of primary aminecontaining molecules. For example, the coated particles were functionalized with TMRcadaverine after film fabrication to permit visualization of the film using fluorescence and
laser scanning confocal microscopy. For these experiments, calcium carbonate particles and
glass beads coated with BPEI/PVDMA films were centrifuged at 1000 g. The acetone
supernatant was decanted by pipette and the coated particles were resuspended in 200 μL of
DMSO containing 0.5 mg/mL TMR-cadaverine. The particles were placed on a
microcentrifuge tube rotator and allowed to react with the TMR-cadaverine for at least 3
hours. After functionalization with TMR-cadaverine, the particles were centrifuged at 1000
g and the TMR-cadaverine solution was decanted. The particles were then rinsed in DMSO
followed by a rinse in deionized water. The particles were then resuspended in acetone until
further use. The same general procedure was used for functionalizing the film-coated
particles with propylamine (50 mM in DMSO), except this reaction was allowed to proceed
overnight. Coated microparticles that were functionalized with TMR-cadaverine or
propylamine were characterized using fluorescence and laser-scanning confocal microscopy
as described below.
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Experiments designed to fabricate hollow multilayered polymer shells were conducted by
first coating calcium carbonate microparticles with BPEI/PVDMA films 5 bilayers thick.
The calcium carbonate cores were then dissolved using the following protocol. Coated
CaCO3 particles were suspended twice in 500 μL of aqueous EDTA (0.2 M, pH = 5) at room
temperature for 30 minutes. After each incubation in EDTA solution, the particles/capsules
were centrifuged at 9000 g for 5 minutes and the supernatant was decanted by pipette. The
capsules were then briefly rinsed in 500 μL of EDTA solution, centrifuged (9000 g for 5
minutes), rinsed briefly in 500 μL deionized water, centrifuged, and resuspended in 250 μL
acetone. The integrity and morphology of the hollow capsules were evaluated using
fluorescence, confocal, and scanning electron microscopy (SEM) as described below.
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Hollow multilayered polymer capsules were obtained from BPEI/PVDMA films coated on
glass beads by etching out the glass core using the following procedure. BPEI/PVDMA
coated glass beads were incubated in 1 mL of 10% hydrofluoric acid (HF) at room
temperature for approximately 24 hours. [WARNING: HF solutions and vapors are
extremely poisonous and corrosive, and may cause extreme burns that are not immediately
painful! Handle with extreme caution, in a chemical fume hood, and using appropriate
protective equipment (gloves, face/eye protection, lab coat, etc.), and neutralize waste
appropriately. Do not store in glass containers.] The HF solution was refreshed twice during
the etching process (after 7 and 22 hours) by centrifuging the capsules at 9000 g for 5
minutes, removing the supernatant by pipette, and resuspending the capsules in fresh 10%
HF solution. After 24 hours, the capsules were centrifuged (9000 g for 5 minutes) and rinsed
three times in 1 mL of deionized water. After the third rinse cycle, the capsules were
resuspended in 500 μL of acetone. The morphology of the hollow capsules was
characterized using confocal and scanning electron microscopy as described below.
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For experiments designed to evaluate the effect of HF treatment on hollow capsules
prepared using CaCO3 cores (see text), hollow capsules were prepared as described above.
After the final rinse in water, the capsules were resuspended in 795 μL of deionized water.
For samples treated with HF in the presence of uncoated glass microspheres, ~3 mg of glass
microspheres were added to the suspension. Then, 205 μL of 48 wt% HF stock solution was
added to these suspensions to yield a final concentration of 10 wt% HF. The HF solution
was refreshed periodically as described above for capsules prepared on glass particles, by
centrifuging the suspension (9000 g for 5 minutes), removing the supernatant, resuspending
the capsules in 795 μL deionized water and adding 205 μL of 48 wt% HF. After 24 hours of
incubation in HF, the capsules were rinsed as described above for capsules prepared on glass
particles and resuspended in 250 μL acetone. The morphology of the hollow capsules after
HF treatment was evaluated using SEM as described below.
Characterization of Microcapsule Stability
Experiments designed to evaluate the stability of BPEI/PVDMA microcapsules in high and
low pH solutions, high ionic strength solutions, and various organic solvents were conducted
as follows. Hollow microcapsules were prepared using CaCO3 cores as described above.
The capsules were centrifuged at 9000 g for 5 minutes, and the acetone was removed by
pipette. The capsules were resuspended in 250 μL of 5 M hydrochloric acid, 5 M sodium
hydroxide, saturated aqueous sodium chloride, acetone, dichloromethane, or methanol. The
suspensions were rotated end-over-end on a mechanical laboratory rotator (Barnstead
Thermolyne, Dubuque, IA) for 22 hours at ambient room temperature. For capsules in 5 M
HCl, 5 M NaOH, or saturated NaCl, the suspensions were centrifuged (9000 g for 5
minutes), the supernatant was removed by pipette, and the capsules were rinsed in 500 μL
deionized water. The capsules were then centrifuged and resuspended in 250 μL deionized
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water. Capsules suspended in organic solvents were not rinsed. Capsule integrity was
evaluated using fluorescence microscopy as described below.
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Fluorescence and Laser-Scanning Confocal Microscopy
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Scanning Electron Microscopy and Energy Dispersive X-Ray Spectroscopy

Samples of coated microparticles or hollow microcapsules for fluorescence and confocal
microscopy were prepared from particle or capsule suspensions in acetone,
dichloromethane, methanol or water. All fluorescence and confocal microscopy images were
acquired with the particles suspended in water. For samples initially suspended in organic
solvents, a 10 μL aliquot of the suspension was placed on a glass microscope slide and the
solvent was allowed to evaporate. A 10 μL drop of deionized water was then placed on the
microscope slide and covered with a glass cover slip. For samples initially suspended in
water, a 10 μL aliquot of the suspension was placed on a glass microscope slide and covered
with a glass cover slip. Fluorescence microscopy images were obtained using an Olympus
IX70 microscope and analyzed using a Metavue (v. 7.1.2.0) software package (Universal
Imaging Corporation). Laser-scanning confocal microscopy (LSCM) was performed using a
Bio-Rad Radiance 2100 MP Rainbow laser-scanning confocal microscope. The confocal
images were acquired using the Bio-Rad LaserSharp 2000 software package. Adobe
Photoshop and ImageJ (National Institutes of Health, Bethesda, MD) were used to further
process both the fluorescence and confocal images.

Samples of uncoated or coated microparticles and hollow microcapsules for scanning
electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS) were prepared
from particle or capsule suspensions in acetone. A 10 μL aliquot of a particle or capsule
suspension was placed in the center of an aluminum SEM sample holder (Ted Pella, Inc.)
and the acetone was allowed to evaporate. The samples were stored in a vacuum dessicator
for at least 1 hour. Prior to SEM imaging and EDS analysis the samples were coated with a
thin layer of gold using a Desk II sputterer (Denton Vacuum, Moorestown, NJ; 30 s at 45
mA, 50 mTorr). SEM was conducted using a LEO DSM 1530 scanning electron microscope
at an accelerating voltage of 3kV. EDS was conducted on the same instrument using an
UltraDry X-ray detector (ThermoFisher Scientific) at an accelerating voltage of 8 kV.
Spectroscopy data were analyzed using the NMSS software package.

Results and Discussion
Fabrication of Hollow Microcapsules by Reactive Layer-by-Layer Assembly on CaCO3
Cores

NIH-PA Author Manuscript

Layer-by-layer assembly has been used to fabricate microcapsules for a broad range of
applications.3a, 15 In past studies, these microcapsules were fabricated on sacrificial
templates by the alternate and repetitive deposition of mutually interacting polymers,
followed by dissolution of the template.3a The properties of the resulting microcapsules
generally depend upon several factors, including the type of molecular interactions used for
film assembly (e.g., electrostatic interactions, hydrogen bonding, disulfide bonding, or
covalent bonding), the structures of the polymers that are incorporated in the films, the
thicknesses of the polymer films, the solution conditions used for film fabrication, and the
conditions to which the capsules are exposed after fabrication. The details of film assembly
and film properties of microcapsules fabricated in a broad range of environments have been
reviewed comprehensively.3a, 15h, 16
In this study, we sought to determine whether BPEI/PVDMA multilayered films could be
fabricated on sacrificial colloidal templates and whether this approach would yield reactive,
covalently crosslinked, and highly stable microcapsules (Figure 1B). We selected calcium
J Mater Chem. Author manuscript; available in PMC 2012 February 14.
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carbonate microparticles as the sacrificial core for fabricating reactive microcapsules in our
initial studies for several reasons. First, calcium carbonate microparticles with diameters
ranging from ~3–6 μm can be readily prepared by precipitation from solutions of calcium
chloride and sodium carbonate.17 Unlike many polymer microparticles used previously as
sacrificial cores for the fabrication of hollow microcapsules, CaCO3 cores are insoluble and
do not swell in the organic solvents used for fabrication of the BPEI/PVDMA multilayered
films described here. In addition, these calcium carbonate particles are porous, and can be
loaded with macromolecular cargoes prior to fabrication of films by soaking the
microparticles in solutions of a macromolecule of interest17 or by co-precipitation14, 18 of a
macromolecule. Finally, calcium carbonate cores can be dissolved in mild, aqueous EDTA
solutions, and the Ca2+ and CO32− ions have been demonstrated to diffuse readily through
the walls of multilayered microcapsules.14 In this study, calcium carbonate microparticles
loaded with FITC-dextran were prepared using a co-precipitation protocol previously
described by DeGeest, et al. (see Materials and Methods for additional details).14 Figure 2A
shows a representative SEM image of a CaCO3 microparticle prepared using this method.
Inspection of this image reveals that the roughly spherical microparticle has a diameter of
~4.5 μm and that it is an amorphous particle composed of smaller (~50–100 nm) CaCO3
nanoparticles.14
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As the first step toward the fabrication of hollow microcapsules, covalent layer-by-layer
assembly was used to coat the surfaces of CaCO3 microparticles with BPEI/PVDMA films
(see Figure 1). Layers of BPEI and PVDMA were deposited on the CaCO3 cores by iterative
and successive cycles of particle suspension, centrifugation, and resuspension in solutions of
BPEI or PVDMA. To allow adsorption of the first layer of polymer on the surfaces of the
microparticles, the CaCO3 microparticles were suspended in a solution of BPEI for 5
minutes. All subsequent layers were allowed to react for 1 minute. Past studies have
demonstrated that one minute reaction times are sufficient for the reaction of the primary
amines on BPEI with the azlactone groups of PVDMA during layer-by-layer assembly on
planar substrates.9a Figure 2B shows a representative SEM image of a CaCO3 microparticle
coated with a BPEI/PVDMA film 5 layer pairs (or ‘bilayers’) thick. The surface of the film
appears uniformly smooth, and no large-scale defects are observed in the film by SEM. The
film coating on the CaCO3 template masks, to some extent, the appearance of the
nanoparticles observed in Figure 2A. While it is experimentally difficult to measure the
thickness of films fabricated on CaCO3 microparticles directly, our past studies of films
fabricated on planar, silicon substrates demonstrate that BPEI/PVDMA films 5 bilayer thick
are approximately 30–60 nm thick.9a We return to a consideration of film thickness again in
the discussion below.
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We have demonstrated in past studies that BPEI/PVDMA films contain residual azlactone
functionality that is accessible for reaction with amine-containing molecules, including
tetramethylrhodamine cadaverine (TMR-cadaverine; a fluorescent molecule) and Dglucamine (a molecule used to prevent cell and protein adhesion on surfaces).9 To further
confirm the presence of BPEI/PVDMA films on the surfaces of the microparticles described
above, we suspended the coated particles in solutions of TMR-cadaverine. Figure 2C shows
a representative confocal microscopy image of coated particles with films that were
functionalized with TMR-cadaverine. The green fluorescence observed in the core of the
particles indicates the presence of FITC-dextran encapsulated in the CaCO3 particles, and
the ring of red fluorescence around each particle arises from the presence of TMRcadeverine. The particles appear uniformly coated, and no defects or uncoated areas were
observed in these films. Coated particles that were first reacted with propylamine (to
consume any residual azlactone functionality)9a before incubating the films with TMRcadaverine did not show evidence of red fluorescence on the particle surface (data not
shown). This result suggests that the red fluorescence observed in Figure 2C results from the
J Mater Chem. Author manuscript; available in PMC 2012 February 14.
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covalent attachment of TMR-cadaverine to azlactone groups in the film and not from the
physical adsorption of TMR. This observation is consistent with our previous studies of
BPEI/PVDMA films on planar macroscopic substrates and natural and synthetic fibers.9a, 9c
In addition to single, isolated particles, Figure 2C reveals the presence of several small
aggregates of up to 8 microparticles. We note that these aggregates could be formed during
the fabrication of the films (e.g., due to reactions between BPEI and PVDMA on adjacent
particles during layer-by-layer assembly) or could result from suspension of the relatively
hydrophobic coated particles in water for imaging. Further optimization of the fabrication
process (to minimize reactions between particles) or functionalization of the coated particles
with more hydrophilic moieties (e.g., glucamine, PEG-amine) could help to reduce such
aggregation. However, the methods described above yielded suspensions of coated particles
sufficient for all characterization studies described below.
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To determine whether the BPEI/PVDMA films described above could withstand removal of
the CaCO3 cores, we treated film-coated particles with aqueous EDTA (0.2 M, pH = 5.0).
The particles were twice suspended in EDTA solution for 30 minutes at room temperature,
then rinsed with EDTA solution and deionized water (see Materials & Methods for
additional details). The resulting capsules were resuspended in acetone for further
characterization. Figure 2D shows a representative SEM image of a hollow BPEI/PVDMA
microcapsule. When dried for characterization by SEM, the microcapsules collapsed and
flattened on the surface of the SEM sample stage, similar to examples in past reports on the
characterization of hollow, multilayered microcapsules.3a By measuring the thicknesses of
vertical folds in these collapsed capsules (see Figure 2D), we estimated the walls of these
capsules (composed of 5 bilayers of BPEI/PVDMA) to be approximately 100 nm thick. This
value is somewhat thicker than the thicknesses of films fabricated with an identical number
of layers on planar, silicon substrates (e.g., 30–60 nm).9a This increased thickness could
result from differences in the chemical composition and physical properties (e.g., porosity)
of the CaCO3 particles compared to silicon and glass substrates, or other factors related to
the fabrication of films on CaCO3 microparticles or post-fabrication treatment to remove the
cores. While ripped or otherwise damaged microcapsules were occasionally observed, the
vast majority of the capsules appeared to remain intact and unbroken. The surfaces of the
microcapsules were similar in appearance to the surfaces of the films before dissolution of
the CaCO3 cores, suggesting that treatment with EDTA did not substantially change the
morphology or general structure of the films.
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We also used fluorescence and confocal microscopy to characterize fluorescently labeled
microcapsules (prepared by reacting the BPEI/PVDMA films with TMR-cadaverine prior to
dissolving the CaCO3 cores) after removal of the CaCO3 cores. For these experiments, a 10
μL aliquot of the capsule suspension was placed on a microscope slide, and the acetone was
allowed to evaporate. The dried microcapsules appeared collapsed and flattened (data not
shown), similar to the capsules imaged by SEM (as shown in Figure 2D). Upon rehydration
with deionized water, however, the microcapsules returned to a spherical shape. Figure 2F
shows a representative confocal microscopy image of the spherical, fluorescently labeled
microcapsules. The presence of bright green fluorescence in the centers of the capsules
demonstrates the ability of these BPEI/PVDMA capsules to encapsulate and retain FITCdextran after removal of the CaCO3 cores. Red fluorescence in the capsule shell results from
TMR-cadaverine that was reacted with the film before dissolution of the core. As described
above for SEM, a small number of broken capsules (identified by large defects in the
capsule wall and substantially reduced levels of green fluorescence) were observed, but the
vast majority of capsules remained intact throughout the fabrication and dissolution
processes as well as subsequent rinsing and centrifugation steps. These results demonstrate
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sacrificial CaCO3 cores to form hollow microcapsules.
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One of the potential advantages of using covalently crosslinked multilayered assemblies to
create polymer microcapsules (compared to electrostatically crosslinked or hydrogenbonded films) is that the capsule shells have the potential to be stable over a wide range of
environmental conditions. For example, depending on the materials selected for the
assembly of polyelectrolyte-based capsules, exposing the capsules to changes in pH or ionic
strength or certain organic solvents can disrupt the interactions that hold the film together
and cause the capsules to disassemble or become permeable to large molecules.3a, 4a, 4b, 6a, 7
To evaluate the stability of our BPEI/PVDMA capsules, we suspended hollow capsules
(fabricated using CaCO3 cores as described above) in saturated aqueous NaCl, 5 M HCl, or
5 M NaOH solutions at room temperature for 22 hours. After incubation, the capsules were
rinsed twice and resuspended in deionized water. Figure 2E shows a representative
fluorescence microscopy image of microcapsules incubated in saturated NaCl solution. The
bright green fluorescence observed in the capsule demonstrates that FITC-dextran
encapsulated by the BPEI/PVDMA films is retained within the capsules, and suggests that
the capsules are stable for at least 22 hours in this high ionic strength solution. Fluorescence
microscopy images of capsules that were incubated in 5 M HCl or 5 M NaOH solutions are
shown in Figure S1 of the Supporting Information and demonstrate that the capsules are
stable for at least 22 hours in both high and low pH solutions. We also evaluated the stability
of these covalently crosslinked capsules in acetone, methanol, and dichloromethane (Figure
S1). The capsules did not appear to be damaged by exposure to these organic solvents. We
note that characterization of the capsules by fluorescence microscopy can be used to identify
capsules that have not ruptured, but it does not permit direct imaging of capsules that may be
disrupted or damaged by exposure to the conditions described above. However, capsules
observed by phase contrast microscopy before and after these stability studies were also
qualitatively similar, suggesting that substantial fractions of these capsules remain intact.
The stability of the BPEI/PVDMA capsules suggests that this approach could be used to
fabricate microcapsules for applications that require encapsulation of species in a wide range
of environmental conditions.
Fabrication of Hollow Microcapsules on Glass Microspheres
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To explore the range of sacrificial templates that could be used as substrates for the
fabrication of BPEI/PVDMA microcapsules, we investigated the fabrication of BPEI/
PVDMA films on soda-lime glass microspheres with diameters ranging from ~10 – 30 μm.
The fabrication of the BPEI/PVDMA films on glass was performed in a similar manner to
the approach described above for fabrication of BPEI/PVDMA films on CaCO3. Figures 3A
and 3B show representative SEM images of an uncoated glass microsphere and a glass
microsphere coated with a BPEI/PVDMA film 5 bilayers thick, respectively. The surfaces of
the uncoated glass particles were rough, with large (up to ~3 μm diameter) features that
protruded from the surfaces of the particles. After coating the glass microspheres with BPEI/
PVDMA films, these features appeared less well defined, suggesting that the polymer films
were covering the surfaces of the particles uniformly.
To further evaluate the uniformity of the films, the coated glass particles were functionalized
with TMR-cadaverine (as described above for CaCO3 cores), and characterized using
confocal microscopy. Figure 3C shows a representative confocal microscopy image of glass
microspheres coated with TMR-functionalized BPEI/PVDMA films. The red fluorescence
observed in the image is uniform around the circumference of the particles, and large-scale
defects in the films are not observed. As described above, films that were functionalized
with propylamine prior to reaction with TMR-cadaverine did not show evidence of red
fluorescence, suggesting that the red fluorescence shown in Figure 3C is a result of
J Mater Chem. Author manuscript; available in PMC 2012 February 14.
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To investigate the ability of the BPEI/PVDMA films to withstand the etching of the glass
templates, the polymer-coated glass microspheres were incubated in hydrofluoric acid (10
wt %) for approximately 24 hours. Figure 3D shows a representative SEM image of
microcapsules after removal of the glass cores and reveals the presence of both intact and
broken capsules. Interestingly, and in sharp contrast to the microcapsules fabricated on
CaCO3 templates described above, these microcapsules remained spherical and did not
collapse when dried. Figure 3E shows the inside surface of a broken, hollow capsule shell.
Broken capsules remained rigid when dried on the SEM stage, retaining a dome- or bowllike shape rather than flattening or collapsing. Previous studies by Caruso et al. have
demonstrated the formation of rigid, hollow microparticles by the layer-by-layer deposition
of silica nanoparticles and PDADMAC on microparticle templates.16, 19 However, to our
knowledge, the fabrication of rigid capsules using layer-by-layer assembly of polymers (i.e.,
without the incorporation of nanoparticles or other non-polymeric additives) has not been
reported previously. Figure 3F shows a representative confocal microscopy image of TMRfunctionalized capsules after dissolution of the glass core. Red fluorescence is observed to
be uniform around the capsules, although some small cracks or other defects in the films are
visible. These cracks and defects are also apparent in the SEM image shown in Figure 3D.
Despite the appearance of these imperfections and holes, the capsules appear to retain their
spherical shapes, further supporting the conclusion that these capsules are more rigid than
the BPEI/PVDMA capsules fabricated on CaCO3 cores described above.
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We conducted a series of experiments to investigate the factors that could contribute to the
formation of the rigid capsules observed in Figure 3D–F. Inspection of the inset in Figure 3E
(which shows a higher magnification view of the capsule shell shown in Figure 3E) reveals
that the capsule shell is approximately 1 μm thick. This is substantially thicker than the films
fabricated on CaCO3 (as estimated above) and in our past reports of BPEI/PVDMA films on
planar substrates.9a Initial examination of the inner surfaces of broken capsules by SEM (as
shown in Figure 3E) also reveals the presence of small particles along the interior walls of
the capsules. One possible explanation for the increase in the thicknesses of these films and
the particles observed along the interior of the walls of the capsules is precipitation of
insoluble compounds (such as CaF2 or MgF2 as discussed below) on or within the polymer
shell during the etching of the glass particles. We used energy dispersive X-ray spectroscopy
(EDS) to characterize the atomic compositions of the coated glass particles and hollow
polymer shells formed by dissolution of the glass core (Table 1). EDS analysis of rigid,
hollow capsules formed by treatment with HF showed significantly reduced silicon and
oxygen content compared to coated glass particles (consistent with the dissolution of SiO2
by HF), and identified the presence of fluorine, calcium, and magnesium in substantial
quantities. In view of the fact that soda-lime glass is composed primarily of silicon dioxide,
with lower amounts of sodium oxide, magnesium oxide, and calcium oxide,20 these results
suggest that calcium fluoride and magnesium fluoride formed during the etching of the glass
core with HF could precipitate within walls of the BPEI/PVDMA capsules. Closer
inspection of the EDS data (Table 1) demonstrates that the fluorine:(calcium + magnesium)
ratio is approximately 2:1, which is consistent with the hypothesis that MgF2 and CaF2 are
present in the rigid microcapsules.
To further test the hypothesis that the precipitates on the BPEI/PVDMA films after the
dissolution of the glass core were metal fluoride salts, we treated the rigid, hollow capsules
with aqueous solutions of EDTA (0.2 M), HCl (1 M), or deionized water for 2 hours.
Calcium and magnesium ions are chelated by EDTA and calcium fluoride and magnesium
fluoride are more soluble in acidic media than at neutral pH. After several rinses in water,
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the particles were resuspended in acetone and imaged using SEM. The results of these
experiments demonstrated that the rigid, hollow microcapsules became flexible and flattened
when dried on the SEM stage following treatment with EDTA (Figure 4B) and HCl (not
shown), whereas capsules that were soaked in water remained rigid. EDS analysis of the
flattened microcapsules indicated a significant reduction in the calcium content of these
samples (Table 1), but indicated that significant levels of magnesium and fluorine (~10, 18
atom %, respectively) were still present in the collapsed capsules. These results suggest that
the metal fluoride salts contribute significantly to the rigidity of the hollow capsules, but that
complete removal of magnesium, calcium, and fluorine may not be necessary to promote the
transition to flexible microcapsules.
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To determine the extent to which HF alone could have resulted in the formation of the rigid
capsules described above, we incubated hollow capsules prepared using CaCO3 templates in
10% HF for ~24 hours. We also performed similar experiments using suspensions of filmcoated CaCO3 templates to which uncoated glass particles were also added (to create
environments that would, upon addition of HF, expose these films to the inorganic
compounds generated by the etching of glass). SEM characterization of capsules treated
with HF, both in the presence and absence of uncoated glass particles, demonstrated that the
hollow capsules remained flexible and that they collapsed when dried on an SEM stage
(Figures 4C and 4D). The image in Figure 4D shows particulate debris on the outside of the
hollow capsules that could arise from insoluble precipitates formed by dissolution of
uncoated glass particles by HF, but these precipitates do not appear to influence the rigidity
of the hollow capsules. These results suggest that the formation of rigid hollow capsules
using glass beads as templates is a consequence of the dissolution of the glass particles (and
the formation of insoluble salts) from the interior of the polymer films during etching, and
not treatment of the film with HF alone or the simple presence of inorganic byproducts of
glass etching in solution.

Summary and Conclusions
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We have demonstrated a layer-by-layer approach to the fabrication of covalently crosslinked
and amine-reactive microcapsules by alternately depositing azlactone-functionalized
PVDMA and BPEI onto sacrificial calcium carbonate and glass templates. Residual
azlactone functionality present in the films was used to functionalize the capsules with a
primary amine-containing fluorophore prior to dissolution of the core templates. The
dissolution of the CaCO3 or glass cores resulted in hollow microcapsules that were stable in
high ionic strength environments, in solutions of both high and low pH, and in several
organic solvents. Characterization of the particles after removal of the cores indicated that
capsules fabricated on calcium carbonate were spherical when wet but collapsed when dried,
whereas capsules fabricated on glass templates remained rigid after removal of the glass
cores. Further characterization of these rigid particles suggested that the rigidity resulted, at
least in part, from the precipitation of metal fluoride salts on the inside of the multilayered
shell. Post-etching treatment of these rigid capsules with aqueous EDTA restored the
flexibility of these capsules.
The work reported here describes a general approach for the fabrication of reactive,
covalently crosslinked microcapsules that could be of interest in a broad range of
fundamental and applied contexts. Our results demonstrate that high molecular weight
FITC-dextran can be encapsulated in BPEI/PVDMA capsules and that it is retained within
these capsules upon exposure to a wide range of solvents, ionic strengths, and values of pH.
These results suggest opportunities to develop microcapsules that could be used to protect,
transport, or control the release of large or small molecules or other agents encapsulated
within the capsules. Our results also demonstrate that the presence of residual azlactone
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groups in the BPEI/PVDMA films can be utilized to functionalize the surfaces of the
capsules. These methods could be used to confer specific chemical or biological
functionality to hollow microcapsules and tune their properties post-fabrication. When
combined, our results provide the basis of approaches for the preparation of reactive,
covalently crosslinked microcapsules for applications in catalysis, imaging, gene and drug
delivery, and a wide range of other fields.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

(A) PVDMA undergoes rapid reactions with primary amines. (B) General scheme for
fabricating hollow, reactive microcapsules.

NIH-PA Author Manuscript
NIH-PA Author Manuscript
J Mater Chem. Author manuscript; available in PMC 2012 February 14.

Saurer et al.

Page 15

NIH-PA Author Manuscript

Figure 2.

Representative SEM images of (A) an uncoated CaCO3 microparticle, (B) a CaCO3
microparticle coated with a (BPEI/PVDMA)5 film, and (D) a hollow microcapsule formed
by dissolving a (BPEI/PVDMA)5 coated CaCO3 core using 0.2M EDTA. (C, F)
Representative confocal microscopy images of CaCO3 microparticles coated with (BPEI/
PVDMA)5 films reacted with TMR-cadaverine. The microparticle and microcapsule cores
were labeled by encapsulation of FITC-dextran during fabrication (see text). (C) Low and
high (inset) magnification images of coated CaCO3 microparticles. (F) Low and high (inset)
magnification images of hollow microcapsules formed by dissolving the CaCO3 core. (E)
Representative fluorescence microscopy image of hollow microcapsules prepared on CaCO3
cores after removal of the cores and incubation in saturated aqueous NaCl for 22 hours.
Scale bars = (A, B, D) 2 μm, (C, E, F) 20 μm, (insets) 3 μm.
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Figure 3.

Representative SEM images of (A) an uncoated glass microparticle, (B) a glass
microparticle coated with a (BPEI/PVDMA)5 film, and (D, E) hollow microcapsules formed
by dissolving (BPEI/PVDMA)5 coated glass cores using 10% HF. The inset of panel E
shows a higher magnification view of the capsule wall. (C) Representative confocal
microscopy images of glass microparticles coated with (BPEI/PVDMA)5 films reacted with
TMR-cadaverine. (F) Representative confocal microscopy image of hollow microcapsules
formed by dissolving coated glass cores using 10% HF. (BPEI/PVDMA)5 films were
reacted with TMR-cadaverine prior to HF treatment. Scale bars = (A, B) 10 μm, (D, E) 20
μm, (inset) 2 μm, (C, F) 30 μm.

NIH-PA Author Manuscript
NIH-PA Author Manuscript
J Mater Chem. Author manuscript; available in PMC 2012 February 14.

Saurer et al.

Page 17

NIH-PA Author Manuscript
Figure 4.
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(A, B) SEM image of hollow microcapsules formed by dissolving (BPEI/PVDMA)5 coated
glass beads in 10% HF. (A) Hollow microcapsules rinsed several times in water to remove
residual HF. (B) Hollow microcapsules soaked in 0.2 M EDTA after removing the glass
cores with HF. (C, D) SEM images of hollow microcapsules formed by dissolving (BPEI/
PVDMA)5 coated CaCO3 microparticles in 0.2M EDTA. (C) Hollow microcapsules were
treated with 10% HF for 24 hours. (D) ~3 mg of uncoated glass beads were added to the
microcapsule suspension, and the suspension was treated with 10% HF for 24 hours. Scale
bars = (A) 100 μm, (B) 20 μm, (C, D) 2 μm.
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22.7 (± 3.3)
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9.6 (± 0.8)
48.4 (± 3.9)

N

11.8 (± 0.4)

C

Undissolved

27.7 (± 9.7)

0.2 (± 0.1)

4.1 (± 0.2)

0.4 (± 0.1)

47.6 (± 5.7)

8.1 (± 1.5)

5.8 (± 0.7)

6.1 (± 2.4)

HF Treated

30.8 (± 12.6)

0.1 (± 0.0)

2.9 (± 1.0)

0.2 (± 0.2)
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7.7 (± 1.7)

5.6 (± 1.4)

5.8 (± 2.7)

HF Treated with H2O Rinses

2.4 (± 1.7)
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9.7 (± 2.7)

4.0 (± 2.9)

17.9 (± 13.2)

11.6 (± 2.1)

11.1 (± 0.9)

43.0 (± 2.8)

HF Treated with EDTA Rinses

EDS data were collected at an accelerating voltage of 8 kV. Data are presented as mean atom % (± standard deviation) as determined by EDS analysis of at least 3 different microparticles or microcapsules
per sample.

*

Atom %

Sample

Results of EDS Characterization of Glass Beads Coated with 5 Bilayers of BPEI/PVDMA*
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